Cargando…

What do we know and when do we know it?

Two essential aspects of virtual screening are considered: experimental design and performance metrics. In the design of any retrospective virtual screen, choices have to be made as to the purpose of the exercise. Is the goal to compare methods? Is the interest in a particular type of target or all...

Descripción completa

Detalles Bibliográficos
Autor principal: Nicholls, Anthony
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270923/
https://www.ncbi.nlm.nih.gov/pubmed/18253702
http://dx.doi.org/10.1007/s10822-008-9170-2
_version_ 1782151785766453248
author Nicholls, Anthony
author_facet Nicholls, Anthony
author_sort Nicholls, Anthony
collection PubMed
description Two essential aspects of virtual screening are considered: experimental design and performance metrics. In the design of any retrospective virtual screen, choices have to be made as to the purpose of the exercise. Is the goal to compare methods? Is the interest in a particular type of target or all targets? Are we simulating a ‘real-world’ setting, or teasing out distinguishing features of a method? What are the confidence limits for the results? What should be reported in a publication? In particular, what criteria should be used to decide between different performance metrics? Comparing the field of molecular modeling to other endeavors, such as medical statistics, criminology, or computer hardware evaluation indicates some clear directions. Taken together these suggest the modeling field has a long way to go to provide effective assessment of its approaches, either to itself or to a broader audience, but that there are no technical reasons why progress cannot be made.
format Text
id pubmed-2270923
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-22709232008-03-21 What do we know and when do we know it? Nicholls, Anthony J Comput Aided Mol Des Article Two essential aspects of virtual screening are considered: experimental design and performance metrics. In the design of any retrospective virtual screen, choices have to be made as to the purpose of the exercise. Is the goal to compare methods? Is the interest in a particular type of target or all targets? Are we simulating a ‘real-world’ setting, or teasing out distinguishing features of a method? What are the confidence limits for the results? What should be reported in a publication? In particular, what criteria should be used to decide between different performance metrics? Comparing the field of molecular modeling to other endeavors, such as medical statistics, criminology, or computer hardware evaluation indicates some clear directions. Taken together these suggest the modeling field has a long way to go to provide effective assessment of its approaches, either to itself or to a broader audience, but that there are no technical reasons why progress cannot be made. Springer Netherlands 2008-02-06 2008-03 /pmc/articles/PMC2270923/ /pubmed/18253702 http://dx.doi.org/10.1007/s10822-008-9170-2 Text en © The Author(s) 2008
spellingShingle Article
Nicholls, Anthony
What do we know and when do we know it?
title What do we know and when do we know it?
title_full What do we know and when do we know it?
title_fullStr What do we know and when do we know it?
title_full_unstemmed What do we know and when do we know it?
title_short What do we know and when do we know it?
title_sort what do we know and when do we know it?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270923/
https://www.ncbi.nlm.nih.gov/pubmed/18253702
http://dx.doi.org/10.1007/s10822-008-9170-2
work_keys_str_mv AT nichollsanthony whatdoweknowandwhendoweknowit